EpiPen maker increases copay, stands firm on high price

The maker of EpiPens offered patients more help to pay for its costly emergency allergy shots but didn’t budge Thursday on the $608 price. The announcement from Mylan triggered a new round of condemnation from consumer groups and politicians, who accuse the company of price-gouging on a potentially lifesaving treatment. Critics stressed that insurers, employers […]